AAIS
IRMD icon

ABN AMRO Investment Solutions’s iRadimed IRMD Stock Holding History

ABN AMRO Investment Solutions’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,863
Closed -$1.59M – 446
2024
Q4 		$1.59M Sell
28,863
-879
-3% -$46.3K 0.03% 275
2024
Q3 		$1.5M Sell
29,742
-628
-2% -$29K 0.03% 281
2024
Q2 		$1.33M Buy
+30,370
New +$1.29M 0.02% 286

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ABN AMRO Investment Solutions's IRMD Position: Q1 2025 in Review

ABN AMRO Investment Solutions sold out of iRadimed (IRMD) in Q1 2025, closing a stake of 28,863 shares — an estimated $1.59M sold.

ABN AMRO Investment Solutions first reported a position in IRMD in Q2 2024 and held it in 3 quarters. The position peaked at $1.59M in Q4 2024. 168 funds tracked by Wall St. Rank hold IRMD as of Q1 2025.

  • ABN AMRO Investment Solutions reported no remaining iRadimed position as of Q1 2025 after selling out during the quarter.
  • ABN AMRO Investment Solutions sold 28,863 iRadimed shares in Q1 2025, an estimated $1.59M.
  • ABN AMRO Investment Solutions first reported a position in iRadimed in Q2 2024 and held it in 3 quarters.
  • ABN AMRO Investment Solutions's iRadimed position peaked at $1.59M in Q4 2024.
  • 168 funds tracked by Wall St. Rank held iRadimed as of Q1 2025.

Based on ABN AMRO Investment Solutions's 13F filing for Q1 2025, filed 27 Aug 2025.